US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist

4.320
-0.090-2.04%

Trading Jan 22 13:42 ET

240.16MMarket Cap-2.34P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 5.450M	--
--	2024/Q4	-- / 8.136M	--
--	2024/Q3	7.808M / 7.010M	--
--	2024/Q2	6.888M / 6.726M	--
--	2024/Q1	5.050M / 7.352M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 5.450M--

--2024/Q4-- / 8.136M--

--2024/Q37.808M / 7.010M--

--2024/Q26.888M / 6.726M--

--2024/Q15.050M / 7.352M--

Unlock Free Earnings Estimates

Open Account

Foghorn Therapeutics Earnings Reports

Foghorn Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 4, 2024 16:22 ET

Foghorn Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8, 2024 07:09 ET

Foghorn Therapeutics | 10-Q: Q1 2024 Earnings Report

May 6, 2024 07:08 ET

Foghorn Therapeutics | 10-K: FY2023 Annual Report

Mar 7, 2024 07:14 ET